Prosecution Insights
Last updated: October 02, 2026

Examiner: JAFFRI, ZEHRA

Tech Center 3700 • Art Units: 3771 3773 3774 3786

This examiner grants 59% of resolved cases

Analysis

Zehra Jaffri has resolved 85 cases in Tech Center 3700. The allowance rate is 58.8% in Art Unit 3771. The median days to allowance is 1238, which serves as a benchmark for the time required to reach a grant. This 1238-day timeline is a significant factor for practitioners to consider when managing their applications under this examiner's review.

The interview lift is 51.8%, showing that interviews are highly effective at increasing the 58.8% baseline allowance rate. With 85 cases of experience, the 51.8% lift is a strong indicator that oral advocacy is a primary strategy for success. Practitioners should prioritize direct communication to improve their chances of success in Art Unit 3771. The 51.8% lift suggests that interviews are a highly productive use of time.

In Tech Center 3700, the examiner's 58.8% allowance rate and 51.8% interview lift offer a clear roadmap for advocacy. The 1238-day median pendency is a reliable estimate for the 85 cases handled. By leveraging the 51.8% lift, attorneys can significantly enhance their chances of reaching a grant within the typical prosecution timeline.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

58.8%
Allow Rate
-11.2% vs TC avg
140
Total Applications
+51.8%
Interview Lift
1238
Avg Prosecution Days
Based on 85 resolved cases, 2023–2026

Rejection Statute Breakdown

1.0%
§101 Eligibility
25.3%
§102 Novelty
47.2%
§103 Obviousness
21.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19187539 LIGATOR DEVICES, SYSTEMS, AND METHODS Non-Final OA Boston Scientific Scimed, Inc.
18929822 ATHERECTOMY BURR ADAPTED FOR RETROGRADE ABLATION WITH LIMITED DRIVESHAFT WINDUP Non-Final OA Boston Scientific Scimed, Inc.
17953748 MEDICAL DEVICE FOR CUTTING A SUTURE DURING A MINIMALLY INVASIVE PROCEDURE Final Rejection BOSTON SCIENTIFIC SCIMED, INC.
17486730 MEDICAL SYSTEMS, DEVICES, AND RELATED METHODS Non-Final OA Boston Scientific Limited
18808518 SUTURING NEEDLES AND RELATED SYSTEMS AND METHODS Final Rejection Intuitive Surgical Operations, Inc.
19039897 OSCILLATING LATERAL/TRANSVERSE MOTION FOR CUT PATH OF INTRAVASCULAR MEDICAL LEAD REMOVAL DEVICE Non-Final OA KONINKLIJKE PHILIPS N.V.
19274143 BALLOON FOR BALLOON CATHETER AND BALLOON CATHETER Non-Final OA KANEKA CORPORATION
19027251 PULL WIRE DETACHMENT FOR INTRAVASCULAR DEVICES Non-Final OA DePuy Synthes Products, Inc.
18937171 ADJUSTABLE STIFFENER FOR SURGICAL INSTRUMENTS Final Rejection Alcon Inc.
17812936 FILTER FOR DEPLOYMENT SYSTEM Final Rejection Edwards Lifesciences Corporation
17729343 ELECTRONICALLY DETECTING PHACOEMULSIFICATION TIP ENGAGEMENT WITH A LENS Final Rejection JOHNSON & JOHNSON SURGICAL VISION, INC.
18420985 SUTURE LOCKING DEVICES WITH INTEGRATED ONE-WAY LOCKING MECHANISMS Non-Final OA ARTHREX, INC.
18891346 DEVICE SET DESIGNED FOR PCNL SURGERY Final Rejection BECTON, DICKINSON AND COMPANY
18118044 CONDUCTING SUTURES AND METHODS FOR FORMING AND USING SAME Final Rejection THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
17730625 FILAMENTARY DEVICES FOR TREATMENT OF VASCULAR DEFECTS Non-Final OA MICROVENTION, INC.
18937726 DEVICES, SYSTEMS AND METHODS FOR VESSEL LIGATION Final Rejection University of Pittsburgh - Of the Commonwealth System of Higher Education
17878406 INTRACORPOREAL SUTURE TYING Final Rejection Children's Medical Center Corporation
18930574 HYBRID SHUNT SYSTEM FOR CAROTID ENDARTERECTOMY Final Rejection THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
18687743 MEDICAL WATER JET AND MEDICAL SYSTEM Non-Final OA BLUESAIL SURGICAL CO., LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month